Secondary tricuspid regurgitation: Do we understand what we would like to treat?
Tricuspid regurgitation has long been a neglected and underestimated entity; its prevalence is significant, and is increasing with the ageing population. Tricuspid regurgitation is often a consequence of chronic left cardiac pathologies or atrial fibrillation. Surgical treatment is recommended for patients with severe symptomatic tricuspid regurgitation or tricuspid annulus dilatation at the time of left heart valve surgery. Secondary tricuspid regurgitation is a complex disease; this review focuses on the need for better understanding of its mechanisms and quantification - mandatory with the advent of new percutaneous treatments.
['Guérin|Anne|A|', 'Dreyfus|Julien|J|', 'Le Tourneau|Thierry|T|', 'Sportouch|Catherine|C|', 'Lairez|Olivier|O|', 'Eicher|Jean-Christophe|JC|', 'Flécher|Erwan|E|', 'Réant|Patricia|P|', 'Donal|Erwan|E|']
D004452:Echocardiography D006439:Hemodynamics D006801:Humans D008279:Magnetic Resonance Imaging D011237:Predictive Value of Tests D011379:Prognosis D012307:Risk Factors D012720:Severity of Illness Index D014261:Tricuspid Valve D014262:Tricuspid Valve Insufficiency
Tricuspid regurgitation Treatment Quantification Insuffisance tricuspide Pathophysiologie Pathophysiology Traitement